NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Depression
Date of first enrollment	08/09/2005
Target sample size	150
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : Paxil tablet. INN of investigational material : Therapeutic category code : 117 Psychotropic agents Dosage and Administration for Investigational material : Paxil tablet will be orally administered at 20 - 40 mg per dose, once daily after dinner

Outcome(s)

Primary Outcome	Primary endpoint is the extent and rate of decrease in HAM-D total score
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 18age old
Age maximum	<= 64age old
Gender	Both
Include criteria	-Main Inclusion criteria- .Male or Female patients .>=18 to <65 years old .Patients with depression or depressive episodes who are diagnosed to have major depressive disorders. .Patients with 14 or higher points in total scores for Items No.1 - 17 on HAM-D .Patients who have continuously received Benzodiazepine anxiolytics -Main Exclusion criteria- .Patients with a strong suicide tendency
Exclude criteria